COMMUNIQUÉS West-GlobeNewswire

Santhera to Present Long-Term Data with Puldysa® (Idebenone) in Duchenne Muscular Dystrophy at Upcoming Medical Congresses
17/09/2019
Pratteln, Switzerland, September 17, 2019 – Santhera Pharmaceuticals (SIX: SANN) will present data on the therapeutic effects of long-term treatment with Puldysa® (idebenone) in Duchenne muscular dystrophy (DMD) at the [...]
Medtronic Announces Robotic-Assisted Surgery Investor Update
17/09/2019
DUBLIN, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will host aRobotic-Assisted Surgery (RAS) Investor Update on Tuesday, September 24, [...]
HMS Acquires VitreosHealth
17/09/2019
Pioneer in Advanced Analytics for Predictive and Prescriptive Health Insights to Enhance Company’s Award-Winning Population Health Management Solution Suite IRVING, Texas, Sept. 16, 2019 (GLOBE NEWSWIRE) -- HMS Holdings [...]
Axiom Real-Time Metrics Celebrates Grand Opening of its New Headquarters in Toronto and Reflects on 18 Years of Growth and Achievement
16/09/2019
TORONTO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is marking the opening of its new global corporate headquarters with a [...]
Emerald Health Therapeutics’ Joint Venture Pure Sunfarms Launches Branded Product Line, Introducing Eight Products for the Recreational Market, and Begins Shipping to Ontario Cannabis Store
16/09/2019
VANCOUVER, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis [...]
Stereotaxis Announces CFO Transition
16/09/2019
ST. LOUIS, Mo., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE American: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that Kimberly Peery [...]
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
16/09/2019
CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)
16/09/2019
Highly statistically significant results at the primary endpoint - statistical significance seen as early as Day 29 Highly statistically significant results on all secondary efficacy endpoints WART-302 is the first of [...]
Tonix Pharmaceuticals Announces Licensing Agreement with Columbia University for the Development of Recombinant Trefoil Family Factor 2 (rTFF2), or TNX-1700, for the Treatment of Gastric and Pancreatic Cancers
16/09/2019
First-in-Class Biologic for the Treatment of Gastric and Pancreatic Cancers NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage [...]
Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results
16/09/2019
PALATINE, Ill., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates [...]
10x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
16/09/2019
PLEASANTON, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the closing of its initial public offering of 11,500,000 shares of its Class A common stock, which includes the exercise [...]
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
16/09/2019
SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Paul Daruwala, chief [...]
Evolve Treatment Centers Joins Silicon Valley Pride Parade
16/09/2019
Evolve San Jose participated in the 2019 LGBTQ parade to spread awareness about mental health resources for struggling adolescents SAN JOSE, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- To demonstrate support for LGBTQ+ [...]
Nextech to Showcase Top Ranked Solutions at Plastic Surgery The Meeting 2019
16/09/2019
Nextech offers a variety of innovative tools and consulting services to help plastic surgery practices optimize practice efficiency and profitability at ASPS TAMPA, Fla., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Nextech [...]
Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete
16/09/2019
Retirement of Pool shares will be Reflected in 31.9% reduction in Outstanding Shares MIRAMAR, Fla., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www. [...]
Intrommune Therapeutics Supports Outcome of FDA Allergenic Product Advisory Committee Vote
16/09/2019
APAC Vote Confirms Benefit of Oral Immunotherapy for Peanut Allergy; Paves Way for Relief for Thousands of Peanut Allergy Sufferers New York, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , a New York-based [...]
Transactions under Novozymes’ stock buyback program
16/09/2019
Please read the full announcement in the attached PDF Attachment 2019_36_Stock_Buybackprogram_EN
Correction: Summary of capital reduction pursuant to Article 32 of the Danish Capital Markets Act
16/09/2019
Please read the full announcement here Attachment 2019_35_Correction_Summary_of_capital_reduction_EN
CellaVision invites to a telephone and audio webcast on September 17, at 11:00 CET to present the signing of an agreement to acquire the French company RAL Diagnostics
16/09/2019
The information was submitted to the public on September 16, 2019 at 18:45 CET CellaVision AB (publ) announced on September 16, 2019, at 18:30 CET that the company has signed an agreement to acquire the French company [...]

Pages